scorecardresearchJubilant Pharmova Share Price Live NSE, BSE, Today - Jubilant Pharmova
Mintgenie
Asian Paints2,927.50-46.30 (-1.56%)
Axis Bank1,140.50-9.25 (-0.80%)
Bajaj Finance6,932.8051.80 (0.75%)
Bajaj Finserv1,627.1011.10 (0.69%)
Bharti Airtel1,279.65-26.50 (-2.03%)
HCL Technologies1,347.85-12.55 (-0.92%)
HDFC Bank1,518.65-14.35 (-0.94%)
Hindustan Unilever2,215.50-9.95 (-0.45%)
ICICI Bank1,142.002.10 (0.18%)
ITC436.25-2.85 (-0.65%)
Indusind Bank1,482.70-23.00 (-1.53%)
Infosys1,416.451.60 (0.11%)
Kotak Mahindra Bank1,547.25-28.55 (-1.81%)
Larsen & Toubro3,499.10-98.50 (-2.74%)
Mahindra & Mahindra2,189.004.55 (0.21%)
Maruti Suzuki India12,491.15-302.60 (-2.37%)
NTPC365.10-4.25 (-1.15%)
Nestle India2,455.60-55.70 (-2.22%)
Power Grid Corporation Of India311.35-2.10 (-0.67%)
Reliance Industries2,868.50-63.60 (-2.17%)
State Bank Of India831.551.50 (0.18%)
Sun Pharmaceutical Industries1,508.40-10.00 (-0.66%)
Tata Consultancy Services3,839.35-24.40 (-0.63%)
Tata Motors1,013.80-14.15 (-1.38%)
Tata Steel166.45-0.90 (-0.54%)
Tech Mahindra1,249.65-17.25 (-1.36%)
Titan Company3,535.40-34.10 (-0.96%)
Ultratech Cement9,786.10-195.15 (-1.96%)
Wipro456.85-0.40 (-0.09%)

Jubilant Pharmova

BSE: 530019 | NSE: JUBLPHARMA | ISIN: INE700A01033 | SECTOR: Biotechnology & Drugs

₹688.50 12.45 (1.84%)

03 May 2024, 09:59 (IST)

  • Open

    677.65

  • High

    688.50

  • Low

    668.10

  • Prev Close

    676.05

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    109.02B

  • Volume

    7.36K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    -
View all metrics

Company Description

  • Biotechnology & Drugs

  • BSE

    530019

  • NSE

    JUBLPHARMA

  • ISIN

    INE700A01033

Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company's segments include Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six manufacturing facilities in India, United States and Canada and a network of approximately 48 radio pharmacies in the United States. The Contract Research and Development Services segment provides drug discovery and development services as well as clinical data software and service solutions. The Proprietary Novel Drugs segment is a patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.

Company Officers

  • Hari Bhartia

    Co-Chairman, Non-Executive Director of the Board

  • Arvind Chokhany

    Chief Financial Officer, Whole-Time Director

  • Syed Kazmi

    President and Chief Executive Officer of Jubilant Therapeutics Inc

  • Shantanu Jha

    Group Chief Human Resource Officer

  • Naresh Kapoor

    Chief Compliance Officer, Company Secretary

  • Arjun Bhartia

    Managing Director, Executive Director

  • Priyavrat Bhartia

    Managing Director, Executive Director

  • Arun Sharma

    Group Treasurer

  • Jinang Parekh

    Additional Director and Whole-time Director

  • K V S Kumar

    Chief Sustainability Officer